연구성과로 돌아가기
2021 연구성과별 연구자 정보 (1161 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Lee, Jae Seung | Lee, JS | 4 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | KHT-9575-2024 | LEE, JAE SEUNG | 0000-0002-2371-0967 | Lee, Jae Seung | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Lee, Jae Seung | Lee, JS | 4 | Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | KHT-9575-2024 | LEE, JAE SEUNG | 0000-0002-2371-0967 | Lee, Jae Seung | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Seung Up | Kim, SU | 5 | Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | J-5409-2012 | Kim, Sung-Won | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Seung Up | Kim, SU | 5 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | J-5409-2012 | Kim, Sung-Won | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Seung Up | Kim, SU | 5 | Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | J-5409-2012 | Kim, Sung-Won | 0000-0002-9658-8050 | Kim, Seung Up | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Park, Jun Yong | Park, JY | 6 | Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | H-7127-2019 | Park, Jun | 0000-0001-6324-2224 | Park, Jun Yong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Park, Jun Yong | Park, JY | 6 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | H-7127-2019 | Park, Jun | 0000-0001-6324-2224 | Park, Jun Yong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Park, Jun Yong | Park, JY | 6 | Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | H-7127-2019 | Park, Jun | 0000-0001-6324-2224 | Park, Jun Yong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Do Young | Kim, D | 7 | Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | F-4608-2014 | Kim, Dong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Do Young | Kim, D | 7 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | F-4608-2014 | Kim, Dong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Do Young | Kim, D | 7 | Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | F-4608-2014 | Kim, Dong | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |||
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Ahn, Sang Hoon | Ahn, SH | 8 | Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | AAV-2600-2020 | SANG-HOON, AHN | 0000-0002-3629-4624 | Ahn, Sang Hoon | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Ahn, Sang Hoon | Ahn, SH | 8 | Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea | AAV-2600-2020 | SANG-HOON, AHN | 0000-0002-3629-4624 | Ahn, Sang Hoon | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Ahn, Sang Hoon | Ahn, SH | 8 | Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea | AAV-2600-2020 | SANG-HOON, AHN | 0000-0002-3629-4624 | Ahn, Sang Hoon | beomkkim@yuhs.ac;psyoung0419@gmail.com; | |
| Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Kim, Beom Kyung | Kim, BK | 9 | 교신저자 | Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | 0000-0002-5363-2496 | Kim, Beom Kyung | beomkkim@yuhs.ac;psyoung0419@gmail.com; |
페이지 이동: